Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

We recently compiled a list of the 11 AI News and Ratings You Shouldn't Miss. In this article, we are going to take a look at where Conduit Pharmaceuticals Inc. (NASDAQ:CDT) stands against the ...

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...

side-effect profile and so on before confirming the lessons learned with only compounds deemed to have good chances of success in Phase III trials is not a new paradigm in drug development ...